Pluripotent Stem Cells in Translation: Early Decisions (Day 2)

Loading... Loading video...

Air date:	Tuesday, March 22, 2011, 7:30:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 266 * This only includes stats from October 2011 and forward.
Category:	Conferences
Runtime:	05:51:31
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The National Institutes of Health and the Food and Drug Administration are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic. For more information, visit http://www.cvent.com/EVENTS/Info/Summary.aspx?e=942182d8-4b08-4a79-8f98-2a3c9df62678

NLM Title:	Pluripotent stem cells in translation : early decisions / NIH and FDA.
Author:	National Institutes of Health (U.S.)
Publisher:
Abstract:	(CIT): The National Institutes of Health and the Food and Drug Administration are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic. The first two day workshop, "Pluripotent Cells in Translation: Early Decisions," is scheduled for March 21 and 22 at Lister Hill Auditorium on the NIH campus in Bethesda, Maryland. The first day will cover pluripotency and its challenges, sources of pluripotent cells, and stem cell banks; the second day will cover making pluripotent stem cells into a product, product characterization, and emerging technologies. The meeting has participation from industry, academic and clinical scientists, the FDA, and the NIH.
Subjects:	Pluripotent Stem Cells
Publication Types:	Congress Webcast
NLM Classification:	QU 325
NLM ID:	101559819
CIT Live ID:	10081
Permanent link:	https://videocast.nih.gov/watch=10081

NIH VideoCasting